You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Eltrombopag for treating chronic immune thrombocytopenia

  • Technology appraisal guidance
  • Reference number: TA293
  • Published:  24 July 2013
  • Last updated:  26 October 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
17 March 2014
(37.14 Kb 10 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 08 May 2014

Back to top